| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Previous Article | Next Article ![]()
Molecular and Cellular Biology, February 2007, p. 1455-1466, Vol. 27, No. 4
0270-7306/07/$08.00+0 doi:10.1128/MCB.01369-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.
Phosphoserine-Binding Protein Is Required for Cardiomyocyte Survival
Center for Cardiovascular Research, Department of Medicine, Department of Cell Biology and Physiology, Washington University School of Medicine, St. Louis, Missouri 63110
Received 26 July 2006/ Returned for modification 15 September 2006/ Accepted 24 November 2006
14-3-3 family members are intracellular dimeric phosphoserine-binding proteins that regulate signal transduction, cell cycle, apoptotic, and metabolic cascades. Previous work with global 14-3-3 protein inhibitors suggested that these proteins play a critical role in antagonizing apoptotic cell death in response to provocative stimuli. To determine the specific role of one family member in apoptosis, mice were generated with targeted disruption of the 14-3-3
gene. 14-3-3
/ mice did not survive embryonic development, but haploinsufficient mice appeared normal at birth and were fertile. Cultured adult cardiomyocytes derived from 14-3-3
+/ mice were sensitized to apoptosis in response to hydrogen peroxide or UV irradiation. 14-3-3
+/ mice were intolerant of experimental myocardial infarction and developed pathological ventricular remodeling with increased cardiomyocyte apoptosis. ASK1, c-jun NH2-terminal kinase, and p38 mitogen-activated protein kinase (MAPK) activation was increased, but extracellular signal-regulated kinase MAPK activation was reduced, in 14-3-3
+/ cardiac tissue. Inhibition of p38 MAPK increased survival in 14-3-3
+/ mice subjected to myocardial infarction. These results demonstrate that 14-3-3
plays a critical antiapoptotic function in cardiomyocytes and that therapeutic agents that increase 14-3-3
activity may be beneficial to patients with myocardial infarction.
Published ahead of print on 4 December 2006.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|